CXCL16 and atherosclerosis: The clearest difference between these two groups was found in the expression of CXCL16 on non-classical monocytes with a nearly twice elevated chemokine expression in patients with psoriasis and atherosclerosis (MFI CXCL16 no atherosclerosis: 20.6; MFI CXCL16 atherosclerosis: 37.2).